Nykturia: diagnosis, classification and treatment

1. Kerrebroeck P, Abrams P, Chaikin D et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the international Continence Society. Neurourol Urodyn 2002; 21(2):179-183.

2. Naitoh P, Kelly TL, Enqlund C. Health effects of sleep deprivation. Occup Med 1990; 5(2): 209-237.

3. Hetta J, Rimón R, Almqvist M. Mood alterations and sleep. Ann Clin Res 1985; 17(5): 252-256.

4. Lindberg E, Janson C, Gislason T et al. Sleep disturbances in a young adult population: can gender differences be explained by differences in psychological status? Sleep 1997; 20(6): 381-387.

5. Broman JE, Lundh LG, Hetta J. Insufficient sleep in the general population. Neurophysiol Clin 1996; 26(1): 30-39.

6. Binq MH, Moller LA, Jennum P et al. Prevalence and bother of nocturia, and cause of sleep interruption in a Danish population of men and women aged 60-80 years. BJU Int 2006; 98(3): 599-604.

7. Kerrebroeck P. Nocturia and Tamsulosin OCAS. European Urology Supplements; 6(12): 723-727.

8. Asplund R, Aberg H. Nocturnal micturition, sleep and well-being in women of ages 40-64 years. Maturitas 1996; 24(1-2): 73-81.

9. Barker JC, Mitteness LS. Nocturia in the elderly. Gerontologist 1988; 28(1): 99-104.

10. Stewart RB, Moore MT, May FE et al. Nocturia: a risk factor for falls in the elderly. J Am Geriatr Soc 1992; 40(12): 1217-1220.

11. Kujubu DA, Sherif RA. Evaluation of nocturia in the Elderly. The Premanete Journal, Winter 2007; 11(1): 37-39.

12. Suqaya K, Nishijima S, Owan T et al. Effects of walking exercise on nocturia in the elderly. Biomed Res 2007; 28(2): 101-105.

13. Donahue JL, Lowenthal DT. Nocturnal polyuria in the elderly person. Am J Med Sci 1997; 314(4): 232- 238.

14. Asplund R. The nocturnal polyuria syndrome (NPS). Gen Pharmacol 1995; 26(6): 1203-1209.

15. Gourova LW, van de Beek C, Spiqt MG et al. Predictive factors for nocturia in elderly men: a cross sectional study in 21 general practices. BJU Int 2006; 97(3): 528-532.

16. Yoshimura K, Terada N, Matsui Y et al. Prevalence of and risk factors for nocturia: Analysis of a health screening program. Int. J Urol 2004; 11(5): 282-287.

17. Saito M, Kondo A, Kato T, Yamada Y. Frequencyvolume charts: comparison of frequency between elderly and adult patients. Br J Urol 1993; 72(1): 38-41.

18. van Cauter E, Copinschi G. Altered hormonal secretions in aging: roles of sleep and circadian rhythms. Aging Male 1998; 1(Suppl): 8.

19. Fitzqerald MP, Litman HJ, Link C, McKinlay JB. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol 2007; 177(4): 1385- 1389.

20. Kripke DF, Garfinkel L, Winqard DL et al. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002; 59(2): 131-136.

21. Coyne KS, Zhou Z, Bhattacharyya SK et al. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 2003; 92(9): 948-954.

22. van Dijk L, Kooij DG, Schellevis FG. Nocturia in the Dutch adult population. BJU Int 2002; 90(7): 644-648.

23. Schatzl G, Temml C, Schmidbauer J et al. Crosssectional study of nocturia in both sexes: analysis of a voluntary health screening project. Urology 2000; 56(1): 71-75.

24. Tikkinen KA, Temmela TL, Huhtala H, Auvinen A. Is nocturia equally common among men and women? A population based study in Finland. J Urol 2006; 175(2): 596-600.

25. Yoshimura K, Kamoto T, Tsukamoto T et al. Seasonal Alterations in Nocturia and Other Storage Symptoms in Three Japanese Communities. Urology 2007; 69(5): 864-870.

26. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committe of the International Continence Society. Neurourol Urodyn 2002; 21(2): 167-178.

27. Weiss JP, Blaivas JG, Stember DS, Chaikin DC. Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn 1999; 18(6): 559-565.

28. Rembratt A, Weiss J, Robertson G. Pathogenesis of nocturia in the elderly: relationship of functional bladder capacity to nocturnal urine output. J Urol 2001; 165(Suppl): 250.

29. Kirkland JL, Lye M. Levy DW, Banerjee AK. Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J 1983; 287(6406): 1665-1667.

30. Asplund R, Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med 1991; 229(2): 131-134.

31. Ozawa T, Oyanaqi K, Tanaka H et al. nucleus in a patient with multiple system atrophy with abnormal circadian rhythm of arginine-vasopressin secretion into plasma. J Neurol Sci 1998; 154(1): 116-121.

32. Graugaard-Jensen C. Ritting S.Djurhuus JC. Nocturia and circadian blood pressure profile in healthy male volunteers. J Urol 2006; 176(3): 1034-1039.

33. Matthiesen TB, Ritting S, Norgaard JP et al. Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. J Urol 1996; 156(4): 1292-1299.

34. Natsume O. A clinical investigation of nocturnal polyuria in patients with nocturia: a dumal variation in arginine vasopressin secretion and its relevance to mean blood pressure. J Urol 2006; 176(2): 660-664.

35. Weiss JP, Blavis JG. Nocturia. J Urol 2000; 163(1): 5-12.

36. Lose G, Lalos O, Freeman RM et al. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. Am J Obstet Gynecol 2003; 189(4): 1106-1113.

37. Mattiasson A, Abrams P, Kerrebroeck P et al. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int 2002; 89(9): 855-862.

38. Le Fanu J. The value of aspirin in controlling the symptoms of nocturnal polyaria. BJU Int 2001; 88(1): 126-127.

39. Addla SK, Adeyoju AB, Nelson D, O'Reilly P. Diclofenac for treatment of nocturia caused by nocturnal polyuria: a prospective, randomised, doubleblind, placebo-controlled crossover study. Eur Urol 2006; 49(4): 720-725.

40. Endeshaw YW, Johnson TM, Kutner MH at al. Sleep-disordered breathing and nocturia in older adults. J Am Geriatr Soc 2004; 52(6): 957-960.

41. Fitzgerald MP, Mulligan M, Parthasarathy S. Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment. Am J Obstet Gynecol 2006; 194(5): 1399-1403.

42. Marqel D, Shochat T, Getzler O et al. Continuous positive airway pressure reduces nocturia in patients with obstructive sleep apnea. Urology 2006; 67(5): 974-977.

43. Yalkut D, Lee LY, Grider J et al. Mechanism of atrial natriuretic peptide release with increased inspiratory resistance. J Lab Clin Med 1996; 128(3): 322-328.

44. Partinen M. Epidemiology of obstructive sleep apnea syndrome. Curr Opin Pulm Med 1995; 1(6): 482-487.

45. Guilleminault C, Lin CM, Goncalves MA, Ramos E. A prospective study of nocturia and the duality of life of elderly patients with obstructive sleep apnea or sleep onset insomnia. J Psychosomatic Res 2004; 56(5): 511-515.

46. Johnson TM 2nd, Jones K, Williford WO et al. Changes in nocturia from medical treatment of bening prostatic hyperplasia: secondary analysis of the department of veterans affairs cooperative study trial. J Urol 2003; 170(1): 145-148.

47. Blaivas JG, Stember DS, Weiss JP. Etiology of voiding symptoms in men: correlation of individual AUA symptom scores with urodynamic and diary parameters. Neurourol Urodyn 1998; 17: 398-399.

48. Cardozo L, Lisec M, Millard R et al. Randomized, double-blind placebo-controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol 2004; 172(5 Pt 1): 1919-1924.

49. Abrams P, Swift S. Solifenacinis effective for the treatment of OAB dry patients: a pooled analysis. Eur Urol 2005; 48(3): 483-487.

50. Chapple CR, Cardozo L, Steers WD, Govier FE. Solifenacin significantly improves all symptoms of overactive bladder syndrome. Int J Clin Pract 2006; 60(8): 959-966.

51. Rudy D, Cline K, Harris R et al. Multicenter phase III. Trial studying trospium chloride in patients with overactive bladder. Urology 2006; 67(2): 275- 280.

52. Zinner N, Gittelman M, Harris R et al. Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial. J Urol 2004; 171(6 Pt 1): 2311-2315.

53. Nitti VW, Dmochowski R, Appell RA et al. Efficacy and tolerability of tolterodine extendedrelease in continent patients with overactive bladder and nocturia. BJU Int 2006; 97(6): 1262- 1266.

54. Rackley R, Weiss JP, Rovnej ES et al. Nighttime dosing with tolterodine reduces overactive bladderrelated nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006; 67: 731-6.

55. Kaplan SA, Roehrborn CG, Dmochowski R et al. Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology 2006; 68(2): 328- 332.

56. Blake-James BT, Rashidian A, Ikeda Y, Emberton M. The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. BJU Int 2007; 99(1): 85-96.

57. Weiss JP, Blaivas JG, Jones M et al. Age related pathogenesis of nocturia in patients with overactive bladder. J Urol 2007; 178(2): 548-551.

58. Weiss JP, Blaivas JG, Stember DS, Brooks MM. Nocturia in adults: etiology and classification. Neurourol Urodyn 1998; 17(5): 467-472.

59. Paick JS, Ku JH, Shin JW et al. Alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction. BJU Int 2006; 97(5): 1017-1023.

60. Koseoglu H, Aslan G, Ozdemir I, Esen A. Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology 2006; 67(6): 1188-1192.

61. Adam P. Evaluation and management of diabetes insipidus. Am Fam Physicain 1997; 55(6): 2146- 2153.